The use of protamine after radiofrequency catheter ablation: A pilot study

Journal of Interventional Cardiac Electrophysiology

Volumn 18, Issue 2, 2007, Pages 155-158

  Patel, Aarti A ^a,b   Clyne, Christopher A ^a,c   Henyan, Nickole N ^d   White, C Michael ^a,b   Zembrowski, Bryan F ^b   Migeed, Magdy ^a,c   Yarlagadda, Ravi ^a   Kluger, Jeffrey ^a,c   Coleman, Craig I ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Bleeding complications; Heparin reversal; Protamine; Radiofrequency catheter ablation; Thrombotic

Indexed keywords

HEPARIN; PROTAMINE;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CATHETER ABLATION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEMATOMA; HOSPITAL DISCHARGE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NURSING CARE; OCCLUSIVE CEREBROVASCULAR DISEASE; PATIENT MOBILITY; PRIORITY JOURNAL; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD LOSS, SURGICAL; CATHETER ABLATION; FEMALE; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PROTAMINES; TACHYCARDIA, VENTRICULAR; THROMBOSIS; WHOLE BLOOD COAGULATION TIME;

EID: 34249700328     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-006-9063-z     Document Type: Article

References (7)

1. Zhou, L., Keane, D., MRCPI, Reed, G., & Ruskin, J. (1999). Thromboembolic complications of cardiac radiofrequency catheter ablation: A review of the reported incidence, pathogenesis and current research directions. Journal of Cardiovascular Electrophysiology, 10, 611-620.
2. Scheinman, M., Calkins, H., Gillette, P., Klein, R., Lerman, B. B., Morady, F., et al. (2003). NASPE policy statement on catheter ablation: Personnel, policy, procedures, and therapeutic recommendations. PACE, 26, 789-799.
3. Product Information: Protamine, Protamine Sulfate(R). (1997). Eli Lilly & Co, Indianapolis, IN.
4. Ducas, J., Chan, M. C. Y., Miller, A., Kashour, T. (2002). Immediate protamine administration and sheath removal following percutaneous coronary intervention: A prospective study of 429 patients. Catheterization and Cardiovascular Interventions, 56, 196-199.
5. Pan, M., De Lezo, J. S., Medina, A., Romero, M., Hernandez, E., Segura, J., et al. (1997). In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. American Journal of Cardiology, 1336-1338.
6. Kereiakes, D. J., Broderick, T. M., Whang, D. D., Anderson, L., & Fye, D. (1997). Partial reversal of heparin anticoagulation by intravenous protamine in abciximab-treated patients undergoing percutaneous intervention. American Journal of Cardiology, 633-634.
7. Scheinmann, M. M., & Huang, S. (2000). The 1998 NASPE prospective catheter ablation registry. PACE, 23, 1020-1028.